GO:0060373 regulation of ventricular cardiac muscle cell membrane depolarization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060373 describes the biological process that modulates the depolarizing phase of the ventricular cardiomyocyte membrane potential, corresponding to the QRS complex on the electrocardiogram.
• The depolarizing upstroke in ventricular myocytes is driven primarily by rapid Na+ influx through voltage-gated sodium channels, with L-type Ca2+ current contributing to the plateau and excitation-contraction coupling.
• Ryanodine receptor channelopathies and altered sarcoplasmic reticulum Ca2+ release can destabilize ventricular depolarization and repolarization, promoting arrhythmias.
• Mitochondrial membrane potential and mitochondrial Ca2+ handling modulate ventricular myocyte excitability and can influence depolarization-related signaling.
• FGF13 regulates cardiomyocyte impulse propagation through connexin-43 trafficking, revealing a non-canonical mechanism that can affect ventricular depolarization.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes that regulate ventricular depolarization in human and animal cardiomyocyte systems.
Description
Regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373) is the biological process that controls the establishment and extent of the depolarizing change in membrane potential of ventricular cardiomyocytes, moving away from the resting potential. This process is fundamental to the normal heartbeat because it determines the speed and fidelity with which electrical excitation spreads through the ventricular myocardium and triggers contraction. The term is synonymous with the electrocardiogram QRS complex and ventricular depolarization, making it a direct bridge between cellular electrophysiology and clinical cardiac readouts. Researchers study GO:0060373 to understand how ion channels, exchangers, and structural proteins cooperate to shape the ventricular action potential upstroke and to identify molecular defects that cause arrhythmias and heart failure. Because ventricular depolarization is exquisitely sensitive to changes in Na+, Ca2+, and K+ handling, even subtle alterations in channel expression, trafficking, or gating can have profound consequences for cardiac rhythm. The process is also modulated by metabolic and mitochondrial signals, linking electrical excitability to cellular energy status and stress responses. In this article, we synthesize the QuickGO definition and verified PubMed literature to provide a research-grade overview of GO:0060373, its molecular players, disease relevance, and the CRISPR-based models used to interrogate it.
regulation of ventricular cardiac muscle cell membrane depolarization At A Glance
| GO ID | GO:0060373 |
|---|---|
| GO term | regulation of ventricular cardiac muscle cell membrane depolarization |
| Ontology | biological_process |
| Synonym | electrocardiogram QRS complex; regulation of ventricular cardiomyocyte membrane depolarization; ventricular depolarization |
| Major function | Modulates the depolarizing phase of the ventricular cardiomyocyte membrane potential, enabling rapid electrical excitation and coordinated contraction. |
| Key ion channels | Voltage-gated sodium channels (NaV1.5/SCN5A), L-type calcium channels (CACNA1C), and potassium channels contribute to the depolarization waveform. |
| Key exchangers | Sarcolemmal sodium-calcium exchanger (NCX) modulates Ca2+ and Na+ homeostasis that indirectly influences depolarization. |
| Cellular context | Ventricular cardiomyocytes, where membrane depolarization triggers excitation-contraction coupling. |
| Disease relevance | Arrhythmogenic channelopathies, heart failure, and aging-related cardiac dysfunction. |
What Is GO:0060373?
GO:0060373 is defined by QuickGO as any process that modulates the establishment or extent of a membrane potential in the depolarizing direction away from the resting potential in a ventricular cardiomyocyte. In practical terms, it covers the events that make the inside of a ventricular heart muscle cell become less negative (or positive) relative to its resting state, primarily through ion channel activity and related regulatory mechanisms. This process is distinct from repolarization, which returns the membrane potential to rest, and it is a key determinant of the QRS complex duration and morphology on the electrocardiogram.
Why Is regulation of ventricular cardiac muscle cell membrane depolarization Important in Cell Biology?
GO:0060373 is important because ventricular depolarization is the initiating electrical event for each heartbeat, and its regulation determines cardiac output, rhythm stability, and susceptibility to lethal arrhythmias. Defects in the ion channels and regulatory proteins that control this process underlie inherited and acquired cardiac diseases, including long QT syndrome, Brugada syndrome, and heart failure. Understanding how this process is regulated at the molecular level is therefore essential for developing targeted therapies and for interpreting genetic variants identified in patients.
• Ventricular depolarization initiates excitation-contraction coupling and is required for effective pumping.
• The QRS complex on the ECG is a direct clinical readout of GO:0060373, making it a translational biomarker.
• Dysregulation of depolarization can cause reentrant arrhythmias and sudden cardiac death.
• Ryanodine receptor channelopathies link abnormal Ca2+ release to depolarization instability.
• Mitochondrial membrane potential and Ca2+ handling modulate ventricular excitability and stress responses.
• FGF13-dependent connexin-43 trafficking affects impulse propagation and can influence depolarization.
• Endothelin receptor A signaling in cardiomyocytes regulates mitophagy and ferroptosis, impacting cardiac aging and electrical function.
• Hypertensive heart failure involves PGC-1α/STAT6/PPARγ-dependent mitophagy and ferroptosis, which can alter cardiomyocyte electrophysiology.
• Sarcolemmal Na+/Ca2+ exchange modulates contraction and Ca2+ homeostasis that feed back on depolarization.
• CRISPR-based models allow causal testing of candidate genes in ventricular depolarization.
What Happens During regulation of ventricular cardiac muscle cell membrane depolarization?
Resting state and threshold
In simple terms: Before a heart cell fires, it sits at a negative resting voltage; a small trigger can push it past a threshold and start the upstroke.
Ventricular cardiomyocytes maintain a negative resting membrane potential primarily through potassium conductance and the Na+/K+ ATPase. When an excitatory stimulus arrives, the membrane potential must reach threshold to activate voltage-gated sodium channels. The regulation of this threshold and resting state is a prerequisite for depolarization and is influenced by extracellular ion concentrations and membrane integrity.
Rapid sodium influx and upstroke
In simple terms: Once threshold is crossed, sodium ions rush into the cell, making the inside positive very quickly.
The depolarizing upstroke of the ventricular action potential is dominated by rapid Na+ influx through voltage-gated sodium channels, particularly NaV1.5 encoded by SCN5A. This phase corresponds to the QRS complex on the ECG and is the core event of GO:0060373. L-type Ca2+ current contributes to the later plateau but also participates in shaping the depolarization waveform under certain conditions.
Calcium handling and excitation-contraction coupling
In simple terms: Calcium entering and leaving stores helps the cell contract and also fine-tunes the electrical signal.
L-type Ca2+ channels activate during depolarization and trigger Ca2+-induced Ca2+ release from the sarcoplasmic reticulum via ryanodine receptors. This Ca2+ signal drives contraction and also modulates the membrane potential through the Na+/Ca2+ exchanger and other transporters. Ryanodine receptor channelopathies can destabilize this coupling and promote arrhythmias.
Mitochondrial modulation
In simple terms: Mitochondria act as calcium and energy sensors that can influence how heart cells depolarize.
Mitochondrial membrane potential modulates mitochondrial Ca2+ uptake in ventricular myocytes, and changes in mitochondrial function can affect cytosolic Ca2+ and ATP supply, indirectly influencing membrane excitability. Endothelin receptor A signaling and mitophagy/ferroptosis pathways have been linked to cardiac aging and electrical remodeling.
Non-canonical regulation by FGF13 and connexin-43
In simple terms: Some proteins affect heart electrical signals without directly being ion channels, for example by moving gap junctions around.
FGF13 regulates cardiomyocyte impulse propagation via connexin-43 trafficking, independent of voltage-gated sodium channels. This non-canonical mechanism can influence the spread of depolarization between cells and highlights additional layers of regulation beyond channel gating.
Key Genes Involved in GO:0060373 regulation of ventricular cardiac muscle cell membrane depolarization
The following genes and proteins are central to the regulation of ventricular cardiac muscle cell membrane depolarization, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Encodes NaV1.5 voltage-gated sodium channel alpha subunit; mediates rapid Na+ influx during upstroke | Mutations cause Brugada syndrome and long QT syndrome; target for antiarrhythmic drug studies |
| CACNA1C | Encodes L-type calcium channel alpha-1C subunit; contributes to plateau and excitation-contraction coupling | Timothy syndrome and Brugada syndrome; calcium channel blocker research |
| RYR2 | Ryanodine receptor 2; mediates sarcoplasmic reticulum Ca2+ release | Channelopathies causing catecholaminergic polymorphic ventricular tachycardia |
| FGF13 | Regulates connexin-43 trafficking and impulse propagation independent of VGSC | Non-canonical regulator of ventricular depolarization and conduction |
| GJA1 | Connexin-43; forms gap junctions for electrical coupling | Trafficking defects affect impulse propagation and depolarization spread |
| EDNRA | Endothelin receptor A; regulates mitophagy and ferroptosis in cardiomyocytes | Cardiac aging and electrical remodeling |
| PPARGC1A | PGC-1α; regulates mitochondrial biogenesis and mitophagy | Hypertensive heart failure and metabolic modulation of excitability |
| STAT6 | Transcription factor involved in PGC-1α/STAT6/PPARγ pathway | Inflammatory and metabolic signaling in heart failure |
| PPARG | PPARγ; regulates metabolic and mitophagy genes | Hypertensive heart failure models |
| SLC8A1 | Na+/Ca2+ exchanger; modulates Ca2+ and Na+ homeostasis | Contraction and depolarization feedback studies |
| ATP2A2 | SERCA2a; sarcoplasmic reticulum Ca2+ ATPase | Calcium handling and arrhythmia research |
| KCNQ1 | Potassium channel contributing to repolarization | Long QT syndrome; repolarization-depolarization interplay |
| KCNH2 | hERG potassium channel | Drug-induced arrhythmia and repolarization studies |
| SCN1B | Sodium channel beta subunit; modulates NaV1.5 gating | Modifier of depolarization and arrhythmia susceptibility |
| CALM1 | Calmodulin; regulates multiple ion channels including CaV and NaV | Calmodulinopathies affecting cardiac excitability |
| CASQ2 | Calsequestrin 2; SR Ca2+ buffering | CPVT and calcium release disorders |
| TRDN | Triadin; SR Ca2+ release complex | Arrhythmia and calcium handling research |
| ANK2 | Ankyrin-B; targets ion channels to membrane domains | Ankyrin-B syndrome and depolarization defects |
How Is regulation of ventricular cardiac muscle cell membrane depolarization Regulated?
The regulation of ventricular cardiac muscle cell membrane depolarization is modulated by multiple signaling pathways. Endothelin receptor A signaling regulates mitophagy and ferroptosis in cardiomyocytes, and its deletion obliterates cardiac aging, suggesting a role in electrical remodeling. The PGC-1α/STAT6/PPARγ pathway activates mitophagy against ferroptosis in hypertensive heart failure, linking metabolic and inflammatory signaling to cardiomyocyte function. Mitochondrial membrane potential modulates mitochondrial Ca2+ handling, which can feed back on cytosolic Ca2+ and membrane excitability. FGF13 regulates connexin-43 trafficking, providing a non-canonical regulatory mechanism for impulse propagation. These pathways represent potential targets for modulating depolarization-related phenotypes.
regulation of ventricular cardiac muscle cell membrane depolarization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Brugada syndrome, long QT syndrome | Knockout or point-mutation hiPSC-cardiomyocytes; patch clamp |
| RYR2 | CPVT, arrhythmogenic channelopathy | Knock-in mouse or hiPSC-CM with RYR2 mutation; Ca2+ imaging |
| EDNRA | Cardiac aging, mitophagy/ferroptosis | Cardiomyocyte-specific knockout mouse; aging studies |
| PPARGC1A | Hypertensive heart failure | Knockout or overexpression in cardiomyocytes; mitophagy assays |
| FGF13 | Conduction disease, impulse propagation | Knockout and rescue in cardiomyocytes; Cx43 trafficking assays |
Arrhythmogenic channelopathies
Mutations in ion channel genes such as SCN5A, CACNA1C, and RYR2 disrupt the regulation of ventricular depolarization and repolarization, leading to arrhythmias including long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. These conditions can cause syncope and sudden cardiac death, making GO:0060373 a critical process for clinical genetics and drug safety testing.
Heart failure and cardiac aging
Heart failure and cardiac aging are associated with electrical remodeling that alters ventricular depolarization. Endothelin receptor A deletion in cardiomyocytes prevents cardiac aging through regulation of mitophagy and ferroptosis, indicating that these pathways contribute to age-related electrical dysfunction. Similarly, hypertensive heart failure involves PGC-1α/STAT6/PPARγ-dependent mitophagy and ferroptosis, which can affect cardiomyocyte viability and electrophysiology.
Conduction system disease
FGF13 regulates cardiomyocyte impulse propagation via connexin-43 trafficking, and disruption of this pathway can impair the spread of depolarization through the ventricular myocardium. This non-canonical mechanism expands the list of genes that can cause conduction system disease beyond classical ion channel mutations.
From regulation of ventricular cardiac muscle cell membrane depolarization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SCN5A alter ventricular depolarization? | SCN5A knockout hiPSC-cardiomyocytes or mouse model; patch clamp and ECG |
| Does a specific point mutation in RYR2 cause Ca2+ leak and arrhythmia? | RYR2 point-mutation knock-in hiPSC-CM or mouse; Ca2+ imaging |
| Can FGF13 rescue connexin-43 trafficking defects? | FGF13 knockout with tagged Cx43 knock-in; live imaging |
| Does EDNRA deletion prevent cardiac aging? | Cardiomyocyte-specific EDNRA knockout mouse; mitophagy and ferroptosis assays |
| Does PGC-1α overexpression protect against hypertensive heart failure? | PGC-1α overexpression in cardiomyocytes; mitophagy and functional assays |
| What is the role of mitochondrial membrane potential in depolarization? | Mitochondrial membrane potential reporters in ventricular myocytes; Ca2+ imaging |
How to Study the regulation of ventricular cardiac muscle cell membrane depolarization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch clamp | Action potential and ionic currents | Direct assessment of depolarization in cardiomyocytes |
| Ca2+ imaging | Intracellular Ca2+ transients | Excitation-contraction coupling and arrhythmia studies |
| Mitochondrial membrane potential assay | Mitochondrial function and Ca2+ uptake | Metabolic modulation of excitability |
| Surface ECG | QRS complex and conduction | In vivo cardiac electrophysiology |
| Optical mapping | Spatiotemporal activation spread | Tissue-level depolarization and arrhythmia mapping |
| CRISPR screen + RNA-seq | Gene essentiality and expression changes | Discovery of novel regulators |
| Western blot / immunostaining | Protein expression and localization | Validation of trafficking and expression changes |
| Proteomics | Protein interactions and modifications | Pathway analysis in disease models |
Patch clamp electrophysiology
Patch clamp recording in isolated ventricular myocytes or hiPSC-cardiomyocytes directly measures action potential upstroke, sodium current, and calcium current, providing the most direct assessment of GO:0060373. This method can quantify changes in depolarization threshold, peak amplitude, and kinetics in response to genetic manipulation.
Calcium imaging and mitochondrial potential assays
Fluorescent Ca2+ indicators and mitochondrial membrane potential dyes allow researchers to monitor intracellular Ca2+ transients and mitochondrial function, which modulate depolarization. These assays are useful for linking metabolic and Ca2+ handling changes to electrical phenotypes.
ECG and optical mapping
Surface ECG in animal models and optical mapping in Langendorff-perfused hearts provide tissue-level readouts of ventricular depolarization, including QRS duration and conduction velocity. These methods bridge cellular findings to whole-organ electrophysiology.
CRISPR-based genetic screens and transcriptomics
CRISPR knockout screens combined with RNA-seq or proteomics can identify novel regulators of ventricular depolarization. For example, FGF13 was identified as a regulator of impulse propagation through connexin-43 trafficking. Such approaches enable unbiased discovery of genes influencing GO:0060373.
How CRISPR Can Be Used to Study GO:0060373 regulation of ventricular cardiac muscle cell membrane depolarization
Knockout
CRISPR knockout of candidate genes such as SCN5A, RYR2, or FGF13 in hiPSC-cardiomyocytes or animal models allows researchers to test whether the gene is required for normal ventricular depolarization. For example, cardiomyocyte-specific deletion of EDNRA has been used to study cardiac aging and mitophagy. Knockout models are essential for establishing causality in GO:0060373 research.
Point Mutation
Point mutations identified in patients, such as those in SCN5A or RYR2, can be introduced into cell models using CRISPR base editing or homology-directed repair. These models help determine whether a specific variant alters depolarization kinetics and arrhythmia susceptibility. Point-mutation models are particularly valuable for channelopathy research.
Knock-in
Knock-in of tagged proteins, such as fluorescently labeled connexin-43 or ion channels, enables live-cell imaging of trafficking and localization. FGF13 regulation of Cx43 trafficking was studied using such approaches. Knock-in models also allow expression of human disease variants in a physiological context.
Overexpression
Overexpression of protective genes such as PGC-1α or dominant-negative constructs can test sufficiency in modulating depolarization and related phenotypes. PGC-1α/STAT6/PPARγ pathway activation has been studied in hypertensive heart failure models. Overexpression is useful for gain-of-function studies and for validating therapeutic targets.
How EDITGENE Supports regulation of ventricular cardiac muscle cell membrane depolarization Research
Researchers studying regulation of ventricular cardiac muscle cell membrane depolarization-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes implicated in GO:0060373.
Contact EDITGENE today to design your custom CRISPR model for regulation of ventricular cardiac muscle cell membrane depolarization research.
Frequently Asked Questions About regulation of ventricular cardiac muscle cell membrane depolarization
What is GO:0060373?
GO:0060373 is the Gene Ontology term for regulation of ventricular cardiac muscle cell membrane depolarization, the process that modulates the depolarizing phase of the membrane potential in ventricular cardiomyocytes.
What genes are involved in regulation of ventricular cardiac muscle cell membrane depolarization?
Key genes include SCN5A, CACNA1C, RYR2, FGF13, GJA1, EDNRA, and PPARGC1A, among others.
What is the QRS complex on an ECG?
The QRS complex represents ventricular depolarization, which is synonymous with GO:0060373.
How does sodium channel dysfunction affect ventricular depolarization?
Mutations in SCN5A can slow or alter the upstroke of the action potential, leading to arrhythmias such as Brugada syndrome.
What role does calcium play in ventricular depolarization?
L-type calcium current contributes to the plateau and triggers calcium release from the sarcoplasmic reticulum, which modulates contraction and electrical stability.
Can CRISPR be used to study ventricular depolarization?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models in cardiomyocytes allow causal testing of genes involved in depolarization.
What diseases are linked to abnormal ventricular depolarization?
Arrhythmogenic channelopathies, heart failure, and cardiac aging are linked to dysregulation of this process.
How is mitochondrial function related to ventricular depolarization?
Mitochondrial membrane potential modulates calcium handling and energy supply, which can influence cardiomyocyte excitability.
What is the role of FGF13 in cardiac conduction?
FGF13 regulates connexin-43 trafficking and impulse propagation independent of voltage-gated sodium channels.
What experimental models are used to study GO:0060373?
Patch clamp, calcium imaging, ECG, optical mapping, and CRISPR-engineered cardiomyocytes are commonly used.
Conclusion
GO:0060373, regulation of ventricular cardiac muscle cell membrane depolarization, is a central biological process that governs the electrical activation of the heart. Its molecular underpinnings involve a complex interplay of ion channels, calcium handling proteins, and non-canonical regulators such as FGF13, with direct implications for arrhythmias, heart failure, and cardiac aging. Continued research using CRISPR-based models and advanced electrophysiology will refine our understanding of this process and accelerate the development of targeted therapies.
References
- 1. Zou R et al.. 2024. Cardiomyocyte-specific deletion of endothelin receptor A (ET(A)) obliterates cardiac aging through regulation of mitophagy and ferroptosis.. Biochim Biophys Acta Mol Basis Dis 1870(2):166958 PMID: 37963542
- 2. Das LT et al.. 2025. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking.. Circ Res 137(12):1522-1539 PMID: 41200819
- 3. Zhao YT et al.. 2015. Arrhythmogenic mechanisms in ryanodine receptor channelopathies.. Sci China Life Sci 58(1):54-8 PMID: 25480325
- 4. Liu C et al.. 2026. Fangchinoline alleviates hypertensive heart failure via PGC-1α/STAT6/PPARγ activation of mitophagy against ferroptosis.. Br J Pharmacol 183(18):5541-5565 PMID: 42380054
- 5. Benitah JP et al.. 2010. L-type Ca(2+) current in ventricular cardiomyocytes.. J Mol Cell Cardiol 48(1):26-36 PMID: 19660468
- 6. Saotome M et al.. 2005. Mitochondrial membrane potential modulates regulation of mitochondrial Ca2+ in rat ventricular myocytes.. Am J Physiol Heart Circ Physiol 288(4):H1820-8 PMID: 15563537
- 7. Bouchard RA et al.. 1993. Regulation of unloaded cell shortening by sarcolemmal sodium-calcium exchange in isolated rat ventricular myocytes.. J Physiol 469:583-99 PMID: 8271217
- 8. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
